𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of metastatic malignant melanoma

✍ Scribed by Ehab Atallah; Lawrence Flaherty

Book ID
107531887
Publisher
Springer
Year
2005
Tongue
English
Weight
311 KB
Volume
6
Category
Article
ISSN
1527-2729

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Treatment of metastatic malignant melano
Treatment of metastatic malignant melanoma with recombinant interferon alfa-2b
✍ T. Dorval; T. Palangie; M. Jouve; E. Garcia-Giralt; E. Falcoff; D. Schwab; M. Le πŸ“‚ Article πŸ“… 1987 πŸ› Springer US 🌐 English βš– 151 KB

Twenty-six patients with histologically proven metastatic malignant melanoma were included in a phase II trial of interferon alfa-2b (Intron A; Schering-Plough). Patients were given 10 X 10(6) IU/m2 of interferon alfa-2b subcutaneously three times a week until major intolerance or progression of dis

Treatment of metastatic malignant melano
Treatment of metastatic malignant melanoma with trimetrexate: A phase II study
✍ Odujinrin, Oluwole ;Goldberg, David ;Doroshow, James ;Leong, Lucille ;Margolin, πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 361 KB

## Abstract Trimetrexate glucuronate, a nonclassical antifolate, was administered to 14 patients with recurrent and progressive metastatic malignant melanoma. Thirteen patients were evaluable for response and toxicity. Five patients had received prior treatment consisting of immunotherapy (one pati

The use of oral BCG in the treatment of
The use of oral BCG in the treatment of metastatic malignant melanoma
✍ Pritchard, Kathleen I. ;Cowan, Donald H. ;Baker, Michael A. ;Osoba, David ;Phill πŸ“‚ Article πŸ“… 1976 πŸ› John Wiley and Sons 🌐 English βš– 515 KB

## Abstract This study assesses the effects of oral BCG, as a single agent, on tumor progression and on cell‐mediated immune function in patients with metastatic malignant melanoma. Thirty patients were studied including 22 with measurable metastatic lesions and 8 with no detectable disease, follow